Co-delivery of doxorubicin and shRNA of Beclin1 by folate receptor targeted pullulan-based multifunctional nanomicelles for combinational cancer therapy
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
New folate receptor targeted nano-micelles enhanced the anticancer effect of doxorubicin by shBeclin1 with the blockade of the autophagy process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Self-citationAutophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
The Beclin 1 network regulates autophagy and apoptosis
Kang, R., Zeh, H. J., Lotze, M. T., & Tang, D. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.191 · Cited by 2,485
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
Wang, R. C., Wei, Y., An, Z., Zou, Z., Xiao, G., Bhagat, G., White, M., Reichelt, J., & Levine, B. (2012) · Science · doi:10.1126/science.1225967 · Cited by 728
Herman-Antosiewicz, A., Johnson, D. E., & Singh, S. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0139 · Cited by 286
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.020 · Cited by 266
Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin
Li, M., Tang, Z., Lv, S., Song, W., Hong, H., Jing, X., Zhang, Y., & Chen, X. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.018 · Cited by 263
Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting
Singh, R. S., Kaur, N., & Kennedy, J. F. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.01.032 · Cited by 262
Engineering Folate–Drug Conjugates to Target Cancer: From Chemistry to Clinic
Vlahov, I. R., & Leamon, C. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc2005522 · Cited by 240
Recent advances in delivery of drug–nucleic acid combinations for cancer treatment
Li, J., Wang, Y., Zhu, Y., & Oupický, D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.010 · Cited by 207
Ultrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery System
Guan, X., Guo, Z., Lin, L., Chen, J., Tian, H., & Chen, X. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02536 · Cited by 201
Zheng, C., Zheng, M., Gong, P., Deng, J., Yi, H., Zhang, P., Zhang, Y., Liu, P., Ma, Y., & Cai, L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.053 · Cited by 200
Hu, Y.-L., Jahangiri, A., DeLay, M., & Aghi, M. K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1076 · Cited by 188
Kaneshiro, T. L., & Lu, Z.-R. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.026 · Cited by 186
Wang, S., Zhang, J., Wang, Y., & Chen, M. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.09.014 · Cited by 186
Cheng, D., Cao, N., Chen, J., Yu, X., & Shuai, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.057 · Cited by 184
Lee, S.-Y., Huh, M. S., Lee, S., Lee, S. J., Chung, H., Park, J. H., Oh, Y.-K., Choi, K., Kim, K., & Kwon, I. C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.007 · Cited by 183
Li, J., Wang, Y., Zhao, M., Tan, C., Li, Y., Le, X., Ji, L., & Mao, Z. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.035 · Cited by 182
Self-citationNa, K., Park, K.-H., Kim, S. W., & Bae, Y. H. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00256-x · Cited by 177
Yin, T., Wang, L., Yin, L., Zhou, J., & Huo, M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.022 · Cited by 172
Pan, H., Liu, L., & Cai, L. (2022) · Biomaterial Engineering · doi:10.1007/978-981-16-5419-0_18 · Cited by 165
Turnover of organelles by autophagy in yeast
Farré, J., Krick, R., Subramani, S. E., & Thumm, M. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.04.015 · Cited by 152
Jiang, J., Yang, S.-J., Wang, J., Yang, L., Xu, Z.-Z., Yang, T., Liu, X.-Y., & Zhang, Q. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.011 · Cited by 149
Self-citationPakunlu, R. I., Wang, Y., Tsao, W., Pozharov, V. P., Cook, T. J., & Minko, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0001 · Cited by 148
Chen, Q., Xu, M., Zheng, W., Xu, T., Deng, H., & Liu, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12792 · Cited by 146
A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model
Wang, X., Li, J., Wang, Y., Koenig, L., Gjyrezi, A., Giannakakou, P., Shin, E. H., Tighiouart, M., Chen, Z. (., Nie, S., et al. (2011) · ACS Nano · doi:10.1021/nn200739q · Cited by 145
Ta, H. T., Dass, C. R., Larson, I. C., Choong, P., & Dunstan, D. E. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.022 · Cited by 144
Butt, A. M., Amin, M. C. I. M., Katas, H., Abdul Murad, N. A., Jamal, R., & Kesharwani, P. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00776 · Cited by 113
A biocleavable pullulan-based vector via ATRP for liver cell-targeting gene delivery
Yang, X., Niu, Y.-L., Zhao, N., Mao, C., & Xu, F. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.036 · Cited by 111
Li, T., Shen, X., Geng, Y., Chen, Z., Li, L., Li, S., Yang, H., Wu, C., Zeng, H., & Liu, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b02963 · Cited by 111
Zhou, X., Chen, L., Nie, W., Wang, W., Qin, M. L., Mo, X., Wang, H., & He, C. (2016) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.6b06759 · Cited by 111
Self-citationA theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy
Lee, S., Yang, C., Peng, C., Wei, M., Chen, K.-C., Yao, C.-J., & Shieh, M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.068 · Cited by 107
Versatile RNA Interference Nanoplatform for Systemic Delivery of RNAs
Choi, K. Y., Silvestre, O. F., Huang, X., Min, K. H., Howard, G. P., Hida, N., Jin, A. J., Carvajal, N., Lee, S. W., Hong, J.-I., et al. (2014) · ACS Nano · doi:10.1021/nn500085k · Cited by 104
Chen, S., Rong, L., Lei, Q., Cao, P., Qin, S., Zheng, D., Jia, H.-Z., Zhu, J., Cheng, S., Zhuo, R., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.013 · Cited by 97
Jia, H.-Z., Zhang, W., Zhu, J., Yang, B., Chen, S., Chen, G., Zhao, Y., Feng, J. X., & Zhang, X. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.006 · Cited by 92
Hydrophobic poly (amino acid) modified PEI mediated delivery of rev-casp-3 for cancer therapy
Fu, C., Lin, L., Shi, H., Zheng, D., Wang, W., Gao, S., Zhao, Y., Tian, H., Zhu, X., & Chen, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.057 · Cited by 79
Qian, J., Xu, M., Suo, A., Xu, W., Liu, T., Liu, X., Yao, Y., & Wang, H. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.12.018 · Cited by 77
Chen, L., Ji, F., Bao, Y., Xia, J., Guo, L., Wang, J., & Li, Y. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.09.019 · Cited by 77
Self-citationWang, J., Dou, B., & Bao, Y. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.08.035 · Cited by 72
Self-citationZhao, S., Lê, V. M., Li, N., Garamus, V. M., Handge, U. A., Liu, J., Zhang, R., Willumeit‐Römer, R., & Zou, A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.027 · Cited by 60
Specific cell targeting with APRPG conjugated PEG–PLGA nanoparticles for treating ovarian cancer
Wang, Y., Liu, P., Duan, Y., Yin, X., Wang, Q., Liu, X., Wang, X., Zhou, J., Wang, W., Qiu, L., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.062 · Cited by 56
Liu, Y., Wang, Y., Zhang, C., Zhou, P., Liu, Y., An, T., Sun, D., Zhang, N., & Wang, Y. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am504203x · Cited by 49
Li, H., Sun, Y., Liang, J., Fan, Y., & Zhang, X. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb01210d · Cited by 36
Chen, Z., Zhu, P., Zhang, Y., Liu, Y., He, Y., Zhang, L., & Gao, Y. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00352 · Cited by 34
Self-citationPartial Beclin 1 silencing aggravates doxorubicin- and Fas-induced apoptosis in HepG2 cells
Bleiberg-Daniel, F., Legrand, A., Pessayre, D., Vadrot, N., Descatoire, V., & Bernuau, D. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i18.2895 · Cited by 33
Wang, X., Wang, J., Bao, Y., Wang, B., Wang, X., & Chen, L. (2014) · RSC Advances · doi:10.1039/c4ra12276c · Cited by 32
Self-citation
Cited by
Current-status and applications of polysaccharides in drug delivery systems
Prasher, P., Sharma, M., Mehta, M., Satija, S., Aljabali, A. A., Tambuwala, M. M., Anand, K., Sharma, N., Dureja, H., Jha, N. K., et al. (2021) · Colloid and Interface Science Communications · doi:10.1016/j.colcom.2021.100418 · Cited by 164
Recent Advances in Nanomicelles Delivery Systems.
Tawfik, S. M., Azizov, S., Elmasry, M. R., Sharipov, M., & Lee, Y.-I. (2020) · Nanomaterials · doi:10.3390/nano11010070 · Cited by 156
Noury, H., Rahdar, A., Ferreira, L. F. R., & Jamalpoor, Z. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104701 · Cited by 107
Qian, M., Zhang, L., Pu, Z., Xia, J., Chen, L., Xia, Y., Cui, H., Wang, J., & Peng, X. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02218f · Cited by 72
Self-citationPolymeric Nanoparticles As Carrier for Targeted and Controlled Delivery of Anticancer Agents
Taghipour-Sabzevar, V., Sharifi, T., & Moghaddam, M. M. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0044 · Cited by 72
Metadata
- Authors
- Chen, L., Qian, M., Zhang, L., Xia, J., Bao, Y., Wang, J., Guo, L., & Li, Y.
- Affiliations
- Dalian University of Technology (CN)
- Dalian Medical University (CN)
- Corresponding author
- Wang, Jingyun
- Li, Yachen
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2018
- Volume
- 8
- Issue
- 32
- Pages
- 17710-17722
- ISSN
- 2046-2069 (ISSN-L)
- PMC
- PMC9080481
- OpenAlex
- W2803886033
- Cited by
- 38
- References
- 50
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 5 · 2018: 3
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- RSC Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (21376039, U1608222)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- doxorubicin, Beclin-1, shRNA, folate receptor targeting, pullulan, nanomicelles, RNA interference, combination cancer therapy, anticancer drug delivery, antitumor efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.